Sharp Edge Labs is developing next generation biosensors based on the Fluorogen Activating Peptide technology of co-Founders Alan Waggoner and Marcel Bruchez
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Sharp Edge Labs makes some noise.